Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-29FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Atenolol by Aurobindo Pharma Limited, granting approval of a generic version under the ANDA proc…
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application from Zydus Lifesciences Limited for Atenolol under ANDA 076900. This confirms approval of a gene…
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for atenolol from Unichem Pharmaceuticals USA, Inc., granting an additional approval related to the …
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for Atenolol by Ipca Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: Mobile Technology for Blood Pressure Management [NA]
A completed clinical trial evaluating mobile technology for blood pressure management sponsored by Stanford University.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease [Phase 2]
A Phase 2b trial of KBP-5074 in patients with uncontrolled hypertension and advanced chronic kidney disease has completed enrollment and pos…
-
FDA approval · 2024-03-21FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Hydrochlorothiazide from Alembic Pharmaceuticals Limited.
-
FDA approval · 2024-03-19FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from Zydus Lifesciences Limited to market the generic co…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension [Phase 3]
Phase 3 trial evaluating efficacy and safety of a drug in patients with dyslipidemia and hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Bingocize: A Novel Mobile Application for Older Adult Health [NA]
A completed clinical trial evaluating the Bingocize mobile app for older adults; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of HCP2102 in essential hypertension has completed.
-
FDA approval · 2024-03-04FDA Approved: ATENOLOL AND CHLORTHALIDONE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for the atenolol and chlorthalidone combination product from Unichem Pharmaceuticals (USA), Inc., ex…
-
FDA approval · 2024-03-01FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for the fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide from Unichem Pharm…
-
FDA approval · 2024-03-01FDA Approved: NADOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nadolol from Aurobindo Pharma Limited under ANDA201893.
-
FDA approval · 2024-03-01FDA Approved: ATENOLOL AND CHLORTHALIDONE — Supplemental Application (Northstar Rx LLC.)
FDA approved a supplemental application for the Atenolol and Chlorthalidone fixed-dose combination from Northstar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring
The trial evaluating ambulatory blood pressure and arterial stiffness telemonitoring for hypertension has completed, and results have been p…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans [Phase 1, Phase 2]
Phase 1/2 trial investigating sulfhydryl-containing antihypertensive therapy and its microvascular effects in humans; the study status is te…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Medication Adherence Clinical Decision Support [NA]
Completed clinical trial evaluating medication adherence decision support in hyperlipidemia and hypertension with results posted in 2024.
-
FDA approval · 2024-02-23FDA Approved: IRBESARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for IRBESARTAN by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation [NA]
Clinical trial update for renal nerve denervation in patients with hypertension and atrial fibrillation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Optimal Medical Treatment of Difficult-to-treat Hypertension [Phase 4]
A Phase 4 trial update on optimal medical treatment for difficult-to-treat hypertension. Current status is UNKNOWN.
-
FDA approval · 2024-02-20FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and valsartan from Lupin Pharmaceuticals under ANDA2028…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ Damage [Phase 2]
Phase 2 clinical trial assessing the effects of dietary nitrate on hypertension-related target organ damage has been completed.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives [Phase 4]
A Phase 4 trial investigating optimal blood pressure and cholesterol targets to prevent recurrent stroke in individuals with hypertension ha…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Prevention of Diabetes and Hypertension [Phase 4]
Phase 4 clinical trial update on prevention of diabetes and hypertension; study terminated.